Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Diamedica Therapeutics Inc
(NQ:
DMAC
)
2.950
UNCHANGED
Streaming Delayed Price
/ Updated:
4:00 PM EST, Dec 9, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
2.950
Bid (Size)
2.640 (1)
Ask (Size)
5.480 (7)
Prev. Close
2.950
Today's Range
2.950 - 2.950
52wk Range
1.700 - 5.930
Shares Outstanding
N/A
Dividend Yield
N/A
Performance
YTD
-8.67%
-8.67%
1 Month
-1.99%
-1.99%
3 Month
+5.73%
+5.73%
6 Month
+3.15%
+3.15%
1 Year
-15.47%
-15.47%
Top News
More News
DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
November 13, 2019
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for kidney diseases and neurological disorders, today provided a business...
Read More
from
Business Wire News Releases
DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019
September 06, 2019
from
GlobeNewswire News Releases
More News
Read More
DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019
November 06, 2019
from
Business Wire News Releases
DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
September 03, 2019
from
GlobeNewswire News Releases
DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference
November 05, 2019
from
Business Wire News Releases
DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease
October 14, 2019
from
Business Wire News Releases
Look Under The Hood: IWC Has 39% Upside
August 19, 2019
category
ETFs
from
ETF Channel
52 Biggest Movers From Friday
December 02, 2019
category
General
,
JNCE
,
SONM
, and 60 more.
from
Benzinga
35 Stocks Moving In Friday's Mid-Day Session
November 29, 2019
category
HIIQ
,
NURO
,
CANF
, and 43 more.
from
Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
November 13, 2019
category
CELG
,
Offerings
,
NXTC
, and 86 more.
from
Benzinga
74 Biggest Movers From Yesterday
November 13, 2019
category
Trading Ideas
,
SNCR
,
ELF
, and 85 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.